Cargando…

Evaluation of Adherence to Oral Hypoglycemic Agent Prescription in Patients with Type 2 Diabetes

BACKGROUND: Diabetes is a global health problem that has affected more than 400 million people worldwide. Adherence to treatment is considered to be one of the most impor tant and deterministic factors in the treatment of diabetes. This study investigates medication adherence and factors af fecting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irani, Mahtab, Yazdi, Mohammad Sarafraz, Irani, Meisam, Sistani, Sina Naghibi, Ghareh, Sahar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SBDR - Society for Biomedical Diabetes Research 2021
Materias:	Original Data
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380091/ https://www.ncbi.nlm.nih.gov/pubmed/33905472 http://dx.doi.org/10.1900/RDS.2020.16.41

Ejemplares similares

Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran
por: Mostafavian, Zahra, et al.
Publicado: (2018)

Corrigendum to “Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran” [Data in Brief 18 (2018) 2047–2050]
por: Mostafavian, Zahra, et al.
Publicado: (2018)

Adherence to Oral Hypoglycemic Agents in Hawaii
por: Lee, Rachel, et al.
Publicado: (2005)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults
por: Bakouni, Hamzah, et al.
Publicado: (2019)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults [Corrigendum]
Publicado: (2019)

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
por: Dawed, Adem Yesuf, et al.
Publicado: (2016)

Adherence to Hypoglycemic Agents in Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Khayyat, Yara A, et al.
Publicado: (2022)

Adherence to oral hypoglycemic medication among patients with diabetes in Saudi Arabia
por: Ahmed, Nahid Osman, et al.
Publicado: (2017)

Use of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents
por: Sodihardjo-Yuen, Fong, et al.
Publicado: (2016)

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database
por: Tanabe, Makito, et al.
Publicado: (2016)

Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan
por: Bashir, Mir Iftikhar, et al.
Publicado: (2012)

Adherence to Hypoglycemic Medication among Insulin-Treated Patients with Type 2 Diabetes
por: Zarei-Shargh, Parisa, et al.
Publicado: (2017)

Prevalence of Early Childhood Caries and the Related Factors among 3-5- Year-Old Children in Babol, Iran
por: Jamshidi, Moein, et al.
Publicado: (2022)

The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
por: Carnevale Schianca, G. P., et al.
Publicado: (2012)

Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin
por: Poudel, Resham R.
Publicado: (2012)

Drug-drug interaction between voriconazole and oral hypoglycemic agents in diabetic rats
por: Kumar, Boyina Hemanth, et al.
Publicado: (2013)

Adherence to Oral Hypoglycemic Drugs among Type 2 Diabetic Patients in a Resource-Poor Setting
por: Sefah, Israel Abebrese, et al.
Publicado: (2020)

Oral hypoglycemic agents: do the ends justify the means?
por: Langer, Oded
Publicado: (2015)

Determinants of Oral Health: Does Oral Health Literacy Matter?
por: Naghibi Sistani, Mohammad Mehdi, et al.
Publicado: (2013)

Association of oral health behavior and the use of dental services with oral health literacy among adults in Tehran, Iran
por: Naghibi Sistani, Mohammad Mehdi, et al.
Publicado: (2017)

Medication Adherence to Oral Hypoglycemic Drugs among Individuals with Type 2 Diabetes Mellitus – A Community Study
por: Aravindakshan, Rajeev, et al.
Publicado: (2021)

Parents’ Oral Health Literacy and its Impact on their Children’s Dental Health Status
por: Khodadadi, Effat, et al.
Publicado: (2016)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
por: Kassem, Sameer A., et al.
Publicado: (2009)

Practical Focus on American Diabetes Association/European Association for the Study of Diabetes Consensus Algorithm in Patients with Type 2 Diabetes Mellitus: Timely Insulin Initiation and Titration (Iran-AFECT)
por: Khamseh, Mohammad Ebrahim, et al.
Publicado: (2017)

Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
por: Kim, Bo-Yeon, et al.
Publicado: (2011)

Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients
por: Alavudeen, Sirajudeen Shaik, et al.
Publicado: (2020)

A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents
por: Watada, Hirotaka, et al.
Publicado: (2021)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
por: Bianchi, Cristina, et al.
Publicado: (2009)

Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
por: Xu, Bilin, et al.
Publicado: (2022)

Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy
por: Cho, Eun Hyung, et al.
Publicado: (2018)

Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors
por: Yoo, Soyeon, et al.
Publicado: (2015)

Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR)
por: Ekström, Nils, et al.
Publicado: (2015)

Quality of Life and General Health in Pregnant Women Conceived with Assisted Reproduction Technologies: A Case-Control Study
por: Sarafraz Yazdi, Mohammad, et al.
Publicado: (2020)

Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients
por: Khan, Mohd Idreesh, et al.
Publicado: (2013)

Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
por: Kim, Gyuri, et al.
Publicado: (2016)

PVA/κ-carrageenan/Au/camptothecin/pegylated-polyurethane/paclitaxel nanofibers against lung cancer treatment
por: Irani, Mohammad, et al.
Publicado: (2022)

Oral health status and associated lifestyle behaviors in a sample of Iranian adults: an exploratory household survey
por: Jahangiry, Leila, et al.
Publicado: (2020)

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
por: Bretzel, Reinhard G., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_g2j197bq9vs3n8hc74kuiqlul5